APLT: Applied Therapeutics, Inc. Stock

by  •  • Comments Off on APLT: Applied Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 50.51
Enterprise Value ($M) -0.25
Book Value ($M) 36.67
Book Value / Share 0.26
Price / Book 1.38
NCAV ($M) 33.73
NCAV / Share 0.24
Price / NCAV 1.50

Profitability (mra)
Return on Invested Capital (ROIC) -1.11
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 3.00
Current Ratio 3.00

Balance Sheet (mrq) ($M)
Current Assets 53.97
Assets 56.91
Liabilities 20.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.46
Operating Income -104.30
Net Income -105.62
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -84.31
Cash from Investing 0.00
Cash from Financing 113.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Venrock Healthcare Capital Partners III, L.P. 4.10 -52.84
05-15 13G/A Schonfeld Strategic Advisors LLC 3.30 -46.68
05-07 13G T. Rowe Price Investment Management, Inc. 8.90
04-30 13G Vanguard Group Inc 5.06
02-14 13G/A Perceptive Advisors Llc 2.40 -71.41
02-14 13G/A Janus Henderson Group Plc 0.00
02-14 13G Vestal Point Capital, LP 9.90 904.37
02-14 13G Alyeska Investment Group, L.P. 5.76 34.64
02-07 13G/A Morgan Stanley 2.50
02-05 13G/A BlackRock, Inc. 8.00 33.90
01-27 13G/A Franklin Resources Inc 1.70
11-13 13G/A Alexandria Real Estate Equities, Inc. 10.30 -2.33
08-14 13D/A Shendelman Shoshana 6.60 -9.76

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 2. LICENSE AGREEMENT 3. FAIR VALUE MEASUREMENTS 4. PREPAID EXPENSES AND OTHER CURRENT ASSETS 5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 6. STOCK‑BASED COMPENSATION 7. STOCKHOLDERS’
2025-04-15 10-K In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 575,128 1,558,982 36.89
2025-05-29 441,806 1,305,375 33.85
2025-05-28 366,826 731,886 50.12
2025-05-27 446,543 1,343,951 33.23

(click for more detail)

Similar Companies
ALT – Altimmune, Inc. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc. AQST – Aquestive Therapeutics, Inc.
ARCT – Arcturus Therapeutics Holdings Inc.


Financial data and stock pages provided by
Fintel.io